Cargando…

Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet

BACKGROUND: Human T‐cell leukaemia virus type 1 (HTLV‐1) tests have been mandated in Japan since 1986, and notification of HTLV‐1‐seropositive donors started in 1999. However, donor knowledge and response to notification has not been assessed. STUDY DESIGN AND METHODS: A questionnaire survey was con...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Hitomi, Sagara, Yasuko, Yamamoto, Midori, Utsunomiya, Atae, Watanabe, Toshiki, Satake, Masahiro, Irita, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293174/
https://www.ncbi.nlm.nih.gov/pubmed/34549482
http://dx.doi.org/10.1111/tme.12821
_version_ 1784749556976582656
author Nakamura, Hitomi
Sagara, Yasuko
Yamamoto, Midori
Utsunomiya, Atae
Watanabe, Toshiki
Satake, Masahiro
Irita, Kazuo
author_facet Nakamura, Hitomi
Sagara, Yasuko
Yamamoto, Midori
Utsunomiya, Atae
Watanabe, Toshiki
Satake, Masahiro
Irita, Kazuo
author_sort Nakamura, Hitomi
collection PubMed
description BACKGROUND: Human T‐cell leukaemia virus type 1 (HTLV‐1) tests have been mandated in Japan since 1986, and notification of HTLV‐1‐seropositive donors started in 1999. However, donor knowledge and response to notification has not been assessed. STUDY DESIGN AND METHODS: A questionnaire survey was conducted among blood donors notified of HTLV‐1 seropositivity regarding their knowledge of HTLV‐1 and unmet information needs. To reduce anxiety among notified individuals and raise awareness of their infection status, we created a booklet containing information that would be useful for these individuals without causing unnecessary anxiety while also requesting that they refrain from donating blood in the future. RESULTS: A questionnaire survey conducted before the distribution of a new booklet revealed that 15.0% of respondents donated blood again despite receiving an HTLV‐1‐seropositive notification at the previous donation. While 62.2% of respondents reacted to the notification favourably, 40.2% expressed anxiety and 32.5% requested information on related diseases and medical institutions for consultation. In the secondary survey after distribution of the new booklet, 87.9% of respondents reported that the information was comprehensible, and an increase in consultations of medical institutions by notification recipients was observed. Furthermore, no re‐visiting donors were observed among the HTLV‐1‐seropositive recipients who were notified using the new information booklet. CONCLUSION: The new information booklet provided enlightenment on HTLV‐1 infection and facilitated the consultation of medical institutions by seropositive donors, leading to an improvement in the health‐related quality of life of seropositive blood donors and the safety of blood products.
format Online
Article
Text
id pubmed-9293174
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-92931742022-07-20 Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet Nakamura, Hitomi Sagara, Yasuko Yamamoto, Midori Utsunomiya, Atae Watanabe, Toshiki Satake, Masahiro Irita, Kazuo Transfus Med Original Articles BACKGROUND: Human T‐cell leukaemia virus type 1 (HTLV‐1) tests have been mandated in Japan since 1986, and notification of HTLV‐1‐seropositive donors started in 1999. However, donor knowledge and response to notification has not been assessed. STUDY DESIGN AND METHODS: A questionnaire survey was conducted among blood donors notified of HTLV‐1 seropositivity regarding their knowledge of HTLV‐1 and unmet information needs. To reduce anxiety among notified individuals and raise awareness of their infection status, we created a booklet containing information that would be useful for these individuals without causing unnecessary anxiety while also requesting that they refrain from donating blood in the future. RESULTS: A questionnaire survey conducted before the distribution of a new booklet revealed that 15.0% of respondents donated blood again despite receiving an HTLV‐1‐seropositive notification at the previous donation. While 62.2% of respondents reacted to the notification favourably, 40.2% expressed anxiety and 32.5% requested information on related diseases and medical institutions for consultation. In the secondary survey after distribution of the new booklet, 87.9% of respondents reported that the information was comprehensible, and an increase in consultations of medical institutions by notification recipients was observed. Furthermore, no re‐visiting donors were observed among the HTLV‐1‐seropositive recipients who were notified using the new information booklet. CONCLUSION: The new information booklet provided enlightenment on HTLV‐1 infection and facilitated the consultation of medical institutions by seropositive donors, leading to an improvement in the health‐related quality of life of seropositive blood donors and the safety of blood products. Blackwell Publishing Ltd 2021-09-21 2021-12 /pmc/articles/PMC9293174/ /pubmed/34549482 http://dx.doi.org/10.1111/tme.12821 Text en © 2021 The Authors. Transfusion Medicine published by John Wiley & Sons Ltd on behalf of British Blood Transfusion Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Nakamura, Hitomi
Sagara, Yasuko
Yamamoto, Midori
Utsunomiya, Atae
Watanabe, Toshiki
Satake, Masahiro
Irita, Kazuo
Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title_full Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title_fullStr Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title_full_unstemmed Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title_short Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet
title_sort improvement of the understanding of blood donors with human t‐cell leukaemia virus type 1 using a new information booklet
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293174/
https://www.ncbi.nlm.nih.gov/pubmed/34549482
http://dx.doi.org/10.1111/tme.12821
work_keys_str_mv AT nakamurahitomi improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT sagarayasuko improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT yamamotomidori improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT utsunomiyaatae improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT watanabetoshiki improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT satakemasahiro improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet
AT iritakazuo improvementoftheunderstandingofblooddonorswithhumantcellleukaemiavirustype1usinganewinformationbooklet